Abiopharma

🔍 PASQUESI JOHN M (Director)

Company: ARCH CAPITAL GROUP LTD. (ACGL)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 2,071 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,071.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,327 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 292,447.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4
• Acquired 1,858 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 294,305.00 | transaction_form_type: 4 | Footnotes: F5, F3, F4
• Holds 0 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Trusts | shares_owned_after: 1,682,128.00
• Holds 0 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 1,527,681.00
• Holds 0 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: Family limited partnership | shares_owned_after: 133,706.00
• Holds 0 shares of Common Shares, $.0011 par value per share (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Limited Liability Company | shares_owned_after: 1,221,693.00

Footnotes:

• F1: Subject to the terms of the restricted share agreement, represents restricted shares that will become vested on the date that is the earlier of 1) one year following the grant date or 2) Arch Capital Group Ltd.'s next Annual General Meeting of Shareholders.
• F2: Represents shares granted as part of the director-elected retainer for serving as a director of the Issuer. Upon grant, the reporting person contributed such shares to a revocable trust. The reporting person and his spouse are the trustees and the beneficiaries.
• F3: Amount includes 1,564 common shares that were previously reported as directly owned by the reporting person and were contributed to the trust on May 6, 2026.
• F4: The common shares are held by a revocable trust. The reporting person and his spouse are the trustees and the beneficiaries.
• F5: Represents shares granted as part of the director-elected retainer for serving as the Chair of the Issuer. Upon grant, the reporting person contributed such shares to a revocable trust. The reporting person and his spouse are the trustees and the beneficiaries.